Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Disease × Vincristine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 128 Lymphoma 107 Lymphoma, Large B-Cell, Diffuse 95 Leukemia 55 Burkitt Lymphoma 50 Lymphoma, Non-Hodgkin 48 Lymphoma, Follicular 37 Lymphoma, Mantle-Cell 33 Hodgkin Disease 25 Retinoblastoma 16 Recurrence 16 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma, T-Cell, Peripheral 16 Lymphoma, Large-Cell, Anaplastic 16 Central Nervous System Neoplasms 16 Neuroblastoma 15 Lymphoma, Large-Cell, Immunoblastic 15 Lymphoma, B-Cell 14 Sarcoma 13 Rhabdomyosarcoma 12 Lymphoma, B-Cell, Marginal Zone 12 Neoplasms 11 Medulloblastoma 11 Immunoblastic Lymphadenopathy 11 Sarcoma, Ewing 10 Lymphoma, T-Cell 10 Leukemia, Lymphocytic, Chronic, B-Cell 9 Leukemia, Biphenotypic, Acute 8 Dendritic Cell Sarcoma, Interdigitating 8 Enteropathy-Associated T-Cell Lymphoma 7

Interventions

Blood Specimen Collection 9 Surveys and Questionnaires 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 Prednisone 4 Colonoscopy 4 Biopsy, Fine-Needle 4 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Mammography 3 Magnetic Resonance Imaging 3 Liquid Biopsy 3 Lenalidomide 3 Interviews as Topic 3 Diagnostic Tests, Routine 3 Cyclophosphamide 3 weifuchun 2 pembrolizumab 2 obinutuzumab 2 Urination 2 Preoperative Exercise 2 Positron Emission Tomography Computed Tomography 2 Methods 2 Melphalan 2 Immunohistochemistry 2 Gemcitabine 2 Exercise 2 Educational Status 2 Doxorubicin 2 Dexamethasone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡